Impact of Early SARS-CoV-2 Antiviral Therapy on Disease Progression

Impact of Early SARS-CoV-2 Antiviral Therapy on Disease Progression

Since the start of the SARS-CoV-2 pandemic, several treatments have been proposed to prevent the progression of the disease. Currently, three antiviral (molnupiravir, nirmaltrevir/r, remdesivir) and two monoclonal antibodies (casirivimab/imdevimab and sotrovimab) are available in Italy. Therefore, w...

Full description

Bibliographic Details
Main Authors: Andrea De Vito, Agnese Colpani, Laura Saderi, Mariangela Puci, Beatrice Zauli, Vito Fiore, Marco Fois, Maria Chiara Meloni, Alessandra Bitti, Cosimo Di Castri, Ivana Maida, Sergio Babudieri, Giovanni Sotgiu, Giordano Madeddu
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Viruses
Subjects:
COVID-19
SARS-CoV-2
vaccination
disease progression
molnupiravir
nirmatrelvir/ritonavir
Online Access:https://www.mdpi.com/1999-4915/15/1/71

Internet

https://www.mdpi.com/1999-4915/15/1/71

Similar Items